Brown-Shimer S, Johnson K A, Hill D E, Bruskin A M
Applied bioTechnology, Division of Oncogene Science, Cambridge, Massachusetts 02142.
Cancer Res. 1992 Jan 15;52(2):478-82.
Many oncogenes encode proteins with a tyrosine kinase activity that appears to be directly involved in the process of transformation. Because these kinases are themselves activated for transformation by tyrosine phosphorylation, proteins which remove phosphate from tyrosine residues, protein tyrosine phosphatases (also termed phosphotyrosine phosphatases and protein phosphotyrosyl phosphatases), are intuitive candidate transformation suppressors. The human PTP1B gene, previously cloned in our laboratory and encoding the low molecular weight protein tyrosine phosphatase PTPase 1B, was introduced into NIH 3T3 cells. Subsequent transformation of these PTPase 1B-expressing cells by an oncogenic form of the human neu gene was suppressed relative to control NIH 3T3 cells. This suppression of transformation was observed in assays for focus formation, anchorage-independent growth, and tumorigenicity. Tumorigenicity assays indicated a complex effect of PTPase 1B expression on transformation.
许多癌基因编码具有酪氨酸激酶活性的蛋白质,这种活性似乎直接参与了细胞转化过程。由于这些激酶本身通过酪氨酸磷酸化被激活以进行转化,因此能从酪氨酸残基上去除磷酸基团的蛋白质,即蛋白质酪氨酸磷酸酶(也称为磷酸酪氨酸磷酸酶和蛋白质磷酸酪氨酰磷酸酶),是直观的候选转化抑制因子。人类PTP1B基因先前在我们实验室中被克隆,它编码低分子量蛋白质酪氨酸磷酸酶PTPase 1B,并被导入NIH 3T3细胞。相对于对照NIH 3T3细胞,这些表达PTPase 1B的细胞随后被人类neu基因的致癌形式转化的能力受到了抑制。在焦点形成、不依赖贴壁生长和致瘤性的检测中都观察到了这种转化抑制现象。致瘤性检测表明PTPase 1B的表达对转化具有复杂的影响。